Senior Director, Medical Affairs Biostatistics
dynetherapeutics
23 days ago
Full-time
On-site
Waltham, MA
$265,000 - $300,000 USD yearly
Leadership
Moneyboard classification: Published range reaches threshold
Reported USD annual base: $265,000–$300,000
Original source: Greenhouse
Company Overview:
Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. We are developing therapeutics that target muscle and the central nervous system (CNS) to address the root cause of disease. The company is advancing clinical programs for Duchenne muscular dystrophy (DMD) and myotonic dystrophy type 1 (DM1) as well as preclinical programs for facioscapulohumeral muscular dystrophy (FSHD), Pompe disease and multiple DMD mutations. At Dyne, we are on a mission to deliver functional improvement for individuals, families and communities. Learn more at https://www.dyne-tx.com/, and follow us on X, LinkedIn and Facebook.
Role Summary:
The Senior Director, Medical Affairs Biostatistics provides strategic, technical, and operational leadership for biostatistics across Medical Affairs evidence-generation activities. This role serves as the primary statistical partner to Medical Affairs leadership and is accountable for shaping statistically rigorous, fit-for-purpose evidence strategies that support scientific communication, external engagement, payer and access needs, and lifecycle planning. Areas of responsibility include Phase IV studies, real-world evidence, observational research, secondary and exploratory analyses of clinical development data, investigator-sponsored research, clinical outcomes assessment (PRO/HRQoL), HEOR and value evidence activities, scientific publications, congress presentations, and other Medical Affairs evidence-generation initiatives. The role requires the ability to operate with a high degree of independence, influence cross-functional and senior stakeholders, translate complex statistical concepts into actionable insights, and build scalable processes, standards, and capabilities. Experience in rare disease drug development, preferably neuromuscular disease, is preferred.Â
This role is based in Waltham, MA.Â
Primary Responsibilities Include:
Strategic Leadership and Evidence PlanningÂ
Serve as the senior Biostatistics lead and subject matter expert for Medical Affairs, providing strategic direction, independent statistical judgment, and hands-on statistical leadershipÂ
Shape integrated evidence-generation strategies and product-level evidence plans in partnership with Medical Affairs, Clinical Development, HEOR, Value & Access, Regulatory, and Commercial stakeholdersÂ
Represent Biostatistics on cross-functional Medical Affairs and evidence-generation teams, influencing strategic decisions and ensuring statistical approaches are scientifically rigorous, practical, and aligned with business and patient needsÂ
Study Design, Analysis, and Evidence GenerationÂ
Lead statistical strategy, study design, methodology, and execution for Phase IV, observational, registry, and real-world evidence studiesÂ
Lead secondary, exploratory, and post hoc analyses of clinical development data to support Medical Affairs strategy, scientific exchange, publications, congress presentations, payer evidence, and lifecycle planningÂ
Provide statistical expertise to HEOR, Value & Access, HTA, and payer-related activities, including methods for evidence generation, interpretation, and communication to external stakeholdersÂ
Provide statistical leadership for clinical outcomes assessment, including PRO/HRQoL analysis, psychometric evaluation, score derivation, endpoint interpretation, and evidence to support publications, payer dossiers, and potential label-enabling activities
Scientific Communication and Cross-Functional PartnershipÂ
Lead the statistical strategy for Medical Affairs publications and scientific communications, including manuscripts, abstracts, congress presentations, advisory boards, investigator-sponsored research, and external scientific collaborationsÂ
Partner with Clinical Development Biostatistics to leverage complementary expertise, ensure consistency across the product lifecycle, and maintain alignment between development, regulatory, and Medical Affairs analysesÂ
Analyze, interpret, and communicate complex results to cross-functional teams, senior leadership, external collaborators, and non-technical audiences in a clear and actionable mannerÂ
Operational Excellence and Vendor OversightÂ
Develop, review, and execute analysis plans, supplemental statistical analysis plans, table/listing/figure shells, dataset specifications, and associated documentation to ensure high-quality, inspection-ready statistical deliverablesÂ
Partner closely with Data Management, Statistical Programming, Clinical Operations, and external vendors to ensure fit-for-purpose data, efficient study execution, and high-quality, timely statistical deliverables supporting Medical Affairs studies and evidence-generation initiativesÂ
Provide oversight of CROs, consultants, and external vendors, including scope, quality, timelines, resourcing, issue escalation, and delivery of statistical services
Functional Leadership and Team DevelopmentÂ
Drive standardization, process improvement, templates, best practices, and functional standards within Biostatistics and across cross-functional teamsÂ
Manage, mentor, and develop direct reports and other statistical colleagues through direct management, matrix leadership, and technical mentorship, fostering technical excellence, collaboration, accountability, and a high-performing team environmentÂ
Education and Skills Requirements:
PhD in Statistics, Biostatistics, or a related quantitative discipline with 10+ years of relevant pharmaceutical, biotechnology, or health-related industry experience; or MS with 12+ years of relevant experienceÂ
Demonstrated experience leading the design, analysis, interpretation, and reporting of analyses within Medical Affairs, including Phase IV, observational, registry, and real-world evidence studiesÂ
Experience supporting scientific publications, congress presentations, investigator-sponsored research, and external scientific
Reported USD annual base: $265,000–$300,000
Original source: Greenhouse
Company Overview:
Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. We are developing therapeutics that target muscle and the central nervous system (CNS) to address the root cause of disease. The company is advancing clinical programs for Duchenne muscular dystrophy (DMD) and myotonic dystrophy type 1 (DM1) as well as preclinical programs for facioscapulohumeral muscular dystrophy (FSHD), Pompe disease and multiple DMD mutations. At Dyne, we are on a mission to deliver functional improvement for individuals, families and communities. Learn more at https://www.dyne-tx.com/, and follow us on X, LinkedIn and Facebook.
Role Summary:
The Senior Director, Medical Affairs Biostatistics provides strategic, technical, and operational leadership for biostatistics across Medical Affairs evidence-generation activities. This role serves as the primary statistical partner to Medical Affairs leadership and is accountable for shaping statistically rigorous, fit-for-purpose evidence strategies that support scientific communication, external engagement, payer and access needs, and lifecycle planning. Areas of responsibility include Phase IV studies, real-world evidence, observational research, secondary and exploratory analyses of clinical development data, investigator-sponsored research, clinical outcomes assessment (PRO/HRQoL), HEOR and value evidence activities, scientific publications, congress presentations, and other Medical Affairs evidence-generation initiatives. The role requires the ability to operate with a high degree of independence, influence cross-functional and senior stakeholders, translate complex statistical concepts into actionable insights, and build scalable processes, standards, and capabilities. Experience in rare disease drug development, preferably neuromuscular disease, is preferred.Â
This role is based in Waltham, MA.Â
Primary Responsibilities Include:
Strategic Leadership and Evidence PlanningÂ
Serve as the senior Biostatistics lead and subject matter expert for Medical Affairs, providing strategic direction, independent statistical judgment, and hands-on statistical leadershipÂ
Shape integrated evidence-generation strategies and product-level evidence plans in partnership with Medical Affairs, Clinical Development, HEOR, Value & Access, Regulatory, and Commercial stakeholdersÂ
Represent Biostatistics on cross-functional Medical Affairs and evidence-generation teams, influencing strategic decisions and ensuring statistical approaches are scientifically rigorous, practical, and aligned with business and patient needsÂ
Study Design, Analysis, and Evidence GenerationÂ
Lead statistical strategy, study design, methodology, and execution for Phase IV, observational, registry, and real-world evidence studiesÂ
Lead secondary, exploratory, and post hoc analyses of clinical development data to support Medical Affairs strategy, scientific exchange, publications, congress presentations, payer evidence, and lifecycle planningÂ
Provide statistical expertise to HEOR, Value & Access, HTA, and payer-related activities, including methods for evidence generation, interpretation, and communication to external stakeholdersÂ
Provide statistical leadership for clinical outcomes assessment, including PRO/HRQoL analysis, psychometric evaluation, score derivation, endpoint interpretation, and evidence to support publications, payer dossiers, and potential label-enabling activities
Scientific Communication and Cross-Functional PartnershipÂ
Lead the statistical strategy for Medical Affairs publications and scientific communications, including manuscripts, abstracts, congress presentations, advisory boards, investigator-sponsored research, and external scientific collaborationsÂ
Partner with Clinical Development Biostatistics to leverage complementary expertise, ensure consistency across the product lifecycle, and maintain alignment between development, regulatory, and Medical Affairs analysesÂ
Analyze, interpret, and communicate complex results to cross-functional teams, senior leadership, external collaborators, and non-technical audiences in a clear and actionable mannerÂ
Operational Excellence and Vendor OversightÂ
Develop, review, and execute analysis plans, supplemental statistical analysis plans, table/listing/figure shells, dataset specifications, and associated documentation to ensure high-quality, inspection-ready statistical deliverablesÂ
Partner closely with Data Management, Statistical Programming, Clinical Operations, and external vendors to ensure fit-for-purpose data, efficient study execution, and high-quality, timely statistical deliverables supporting Medical Affairs studies and evidence-generation initiativesÂ
Provide oversight of CROs, consultants, and external vendors, including scope, quality, timelines, resourcing, issue escalation, and delivery of statistical services
Functional Leadership and Team DevelopmentÂ
Drive standardization, process improvement, templates, best practices, and functional standards within Biostatistics and across cross-functional teamsÂ
Manage, mentor, and develop direct reports and other statistical colleagues through direct management, matrix leadership, and technical mentorship, fostering technical excellence, collaboration, accountability, and a high-performing team environmentÂ
Education and Skills Requirements:
PhD in Statistics, Biostatistics, or a related quantitative discipline with 10+ years of relevant pharmaceutical, biotechnology, or health-related industry experience; or MS with 12+ years of relevant experienceÂ
Demonstrated experience leading the design, analysis, interpretation, and reporting of analyses within Medical Affairs, including Phase IV, observational, registry, and real-world evidence studiesÂ
Experience supporting scientific publications, congress presentations, investigator-sponsored research, and external scientific